BioMarin Pharmaceutical Inc. (BMRN) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 766.21M | 874.57M | 776.13M | 825.41M | 745.14M | 747.31M | 745.74M | 712.03M | 648.83M | 646.21M | 581.33M | 595.27M |
| Revenue Growth % | 2.83% | 17.03% | 4.08% | 15.92% | 14.84% | 15.65% | 28.28% | 19.61% | 8.79% | 20.22% | 15.04% | 11.52% |
| Cost of Goods Sold | 195M | 295.1M | 140.09M | 150.09M | 151.56M | 136.14M | 188.46M | 130.46M | 125.18M | 135.48M | 128.04M | 130.62M |
| COGS % of Revenue | 25.45% | 33.74% | 18.05% | 18.18% | 20.34% | 18.22% | 25.27% | 18.32% | 19.29% | 20.97% | 22.03% | 21.94% |
| Gross Profit | 571.21M | 579.47M | 636.05M | 675.32M | 593.59M | 611.17M | 557.28M | 581.57M | 523.65M | 510.73M | 453.29M | 464.66M |
| Gross Margin % | 74.55% | 66.26% | 81.95% | 81.82% | 79.66% | 81.78% | 74.73% | 81.68% | 80.71% | 79.03% | 77.97% | 78.06% |
| Gross Profit Growth % | -3.77% | -5.19% | 14.13% | 16.12% | 13.36% | 19.67% | 22.94% | 25.16% | 13.6% | 24.49% | 16.51% | 13.15% |
| Operating Expenses | 441.57M | 500.08M | 682.74M | 398.43M | 369.69M | 449.77M | 443.39M | 461.12M | 435.19M | 496.51M | 422.76M | 399.09M |
| OpEx % of Revenue | 57.63% | 57.18% | 87.97% | 48.27% | 49.61% | 60.18% | 59.46% | 64.76% | 67.07% | 76.83% | 72.72% | 67.04% |
| Selling, General & Admin | 258.29M | 802.12M | 268.42M | 232.3M | 206.1M | 266.6M | 253.5M | 263M | 225.9M | 275M | 172.6M | 206.1M |
| SG&A % of Revenue | 33.71% | 91.72% | 34.58% | 28.14% | 27.66% | 35.67% | 33.99% | 36.94% | 34.82% | 42.56% | 29.69% | 34.62% |
| Research & Development | 178.8M | 192.41M | 409.48M | 161.31M | 158.73M | 173.51M | 184.9M | 183.79M | 204.99M | 206.25M | 191.31M | 177.36M |
| R&D % of Revenue | 23.34% | 22% | 52.76% | 19.54% | 21.3% | 23.22% | 24.79% | 25.81% | 31.59% | 31.92% | 32.91% | 29.8% |
| Other Operating Expenses | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 137.64M | 79.39M | -46.69M | 276.89M | 223.89M | 161.41M | 113.89M | 120.45M | 88.46M | 14.22M | 30.52M | 65.57M |
| Operating Margin % | 17.96% | 9.08% | -6.02% | 33.55% | 30.05% | 21.6% | 15.27% | 16.92% | 13.63% | 2.2% | 5.25% | 11.01% |
| Operating Income Growth % | -38.52% | -50.81% | -141% | 129.87% | 153.1% | 1035.15% | 273.11% | 83.71% | 41.76% | 158.04% | 1362.93% | 67.47% |
| EBITDA | 154.05M | 99.83M | -28.2M | 295.45M | 245.96M | 185.01M | 132.9M | 146.91M | 115.81M | 41.08M | 56.21M | 90.98M |
| EBITDA Margin % | 20.11% | 11.41% | -3.63% | 35.79% | 33.01% | 24.76% | 17.82% | 20.63% | 17.85% | 6.36% | 9.67% | 15.28% |
| EBITDA Growth % | -37.37% | -46.04% | -121.22% | 101.1% | 112.38% | 350.37% | 136.43% | 61.47% | 30.38% | 77409.43% | 151.11% | 41.23% |
| D&A (Non-Cash Add-back) | 16.41M | 20.44M | 18.49M | 18.56M | 22.07M | 23.61M | 19.01M | 26.46M | 27.35M | 26.86M | 25.68M | 25.42M |
| EBIT | 137.64M | -24.38M | -23.75M | 300.55M | 240.95M | 171.89M | 137.41M | 135.71M | 109.09M | 24.83M | 45.45M | 74.56M |
| Net Interest Income | 7.6M | 16.43M | 15.28M | 16.15M | 16.15M | 15.04M | 15.09M | 16.21M | 15.82M | 11.95M | 11.96M | 8.86M |
| Interest Income | 22.56M | 19.21M | 17.85M | 18.83M | 19.01M | 17.68M | 18.05M | 19.79M | 19.36M | 18.04M | 15.74M | 12.61M |
| Interest Expense | 14.96M | 2.78M | 2.58M | 2.68M | 2.86M | 2.58M | 2.97M | 3.57M | 3.55M | 6.1M | 3.78M | 3.75M |
| Other Income/Expense | 11.56M | -106.54M | 20.37M | 20.98M | 14.2M | 8.23M | 20.55M | 11.68M | 17.09M | 5.11M | 11.14M | 5.24M |
| Pretax Income | 141.2M | -27.15M | -26.32M | 297.87M | 238.09M | 169.64M | 134.44M | 132.14M | 105.55M | 19.33M | 41.67M | 70.81M |
| Pretax Margin % | 18.43% | -3.1% | -3.39% | 36.09% | 31.95% | 22.7% | 18.03% | 18.56% | 16.27% | 2.99% | 7.17% | 11.9% |
| Income Tax | 35.68M | 19.42M | 4.42M | 57.34M | 52.4M | 44.7M | 28.36M | 24.96M | 16.89M | -1.05M | 1.29M | 14.77M |
| Effective Tax Rate % | 25.27% | -71.52% | -16.79% | 19.25% | 22.01% | 26.35% | 21.1% | 18.89% | 16% | -5.42% | 3.1% | 20.86% |
| Net Income | 105.53M | -46.57M | -30.74M | 240.53M | 185.69M | 124.94M | 106.08M | 107.17M | 88.66M | 20.38M | 40.38M | 56.04M |
| Net Margin % | 13.77% | -5.33% | -3.96% | 29.14% | 24.92% | 16.72% | 14.22% | 15.05% | 13.66% | 3.15% | 6.95% | 9.41% |
| Net Income Growth % | -43.17% | -137.28% | -128.98% | 124.43% | 109.43% | 513.22% | 162.72% | 91.25% | 74.35% | 8282.73% | 707.01% | 102.57% |
| Net Income (Continuing) | 105.53M | -46.57M | -30.74M | 240.53M | 185.69M | 124.94M | 106.08M | 107.17M | 88.66M | 20.38M | 40.38M | 56.04M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.54 | -0.22 | -0.16 | 1.23 | 0.95 | 0.64 | 0.55 | 0.55 | 0.46 | 0.11 | 0.21 | 0.29 |
| EPS Growth % | -43.16% | -134.38% | -129.09% | 123.64% | 106.52% | 481.82% | 161.9% | 89.66% | 76.92% | - | 686.59% | 93.33% |
| EPS (Basic) | 0.55 | -0.24 | -0.16 | 1.25 | 0.97 | 0.66 | 0.57 | 0.56 | 0.47 | 0.11 | 0.21 | 0.30 |
| Diluted Shares Outstanding | 197.67M | 197.39M | 192.03M | 196.64M | 196.47M | 196.58M | 197.15M | 200.5M | 199.26M | 191.84M | 191.17M | 195M |
| Basic Shares Outstanding | 192.5M | 191.79M | 192.03M | 191.44M | 190.97M | 190.69M | 190.43M | 190.11M | 188.87M | 188.48M | 188.22M | 187.95M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |